Control of cell growth by c-Myc in the absence of cell division
- PMID: 10556095
- DOI: 10.1016/s0960-9822(99)80507-7
Control of cell growth by c-Myc in the absence of cell division
Abstract
The c-Myc protein (Myc) is a transcription factor, and deregulated expression of the c-myc gene (myc) is frequently found in tumours. In Burkitt's lymphoma (BL), myc is transcriptionally activated by chromosomal translocation. We have used a B-cell line called P493-6 that carries a conditional myc allele to elucidate the role of Myc in the proliferation of BL cells. Regulation of proliferation involves the coordination of cell growth (accumulation of cell mass) and cell division [1] [2] [3]. Here, we show that division of P493-6 cells was strictly dependent on the expression of the conditional myc allele and the presence of foetal calf serum (FCS). More importantly, cell growth was regulated by Myc without FCS: Myc alone induced an increase in cell size and positively regulated protein synthesis. An increase in protein synthesis is thought to be one of the causes of cell mass increase. Furthermore, Myc stimulated metabolic activities, as indicated by the acidification of culture medium and the activation of mitochondrial enzymes. Our results confirm the model that Myc is involved in the regulation of cell growth [4] and provide, for the first time, direct evidence that Myc induces cell growth, that is, an increase in cell size, uncoupled from cell division.
Similar articles
-
Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line.Oncogene. 2005 Jan 13;24(3):520-4. doi: 10.1038/sj.onc.1208198. Oncogene. 2005. PMID: 15516975
-
Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression.J Cell Physiol. 2005 Apr;203(1):277-85. doi: 10.1002/jcp.20229. J Cell Physiol. 2005. PMID: 15468060
-
Cell cycle activation by c-myc in a burkitt lymphoma model cell line.Int J Cancer. 2000 Sep 15;87(6):787-93. doi: 10.1002/1097-0215(20000915)87:6<787::aid-ijc4>3.0.co;2-6. Int J Cancer. 2000. PMID: 10956386
-
c-MYC impairs immunogenicity of human B cells.Adv Cancer Res. 2007;97:167-88. doi: 10.1016/S0065-230X(06)97007-9. Adv Cancer Res. 2007. PMID: 17419945 Review.
-
The role of c-myc in cellular growth control.Oncogene. 1999 May 13;18(19):2988-96. doi: 10.1038/sj.onc.1202751. Oncogene. 1999. PMID: 10378694 Review.
Cited by
-
Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma.Nat Commun. 2024 Feb 1;15(1):963. doi: 10.1038/s41467-024-45128-y. Nat Commun. 2024. PMID: 38302473 Free PMC article.
-
Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival.PLoS Pathog. 2019 Sep 13;15(9):e1008030. doi: 10.1371/journal.ppat.1008030. eCollection 2019 Sep. PLoS Pathog. 2019. PMID: 31518366 Free PMC article.
-
MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products.Aging Dis. 2024 Apr 1;15(2):640-697. doi: 10.14336/AD.2023.0520. Aging Dis. 2024. PMID: 37450923 Free PMC article. Review.
-
The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome.Breast Cancer Res. 2008;10(2):R28. doi: 10.1186/bcr1985. Epub 2008 Mar 29. Breast Cancer Res. 2008. PMID: 18373870 Free PMC article.
-
A non-genetic model of vascular shunts informs on the cellular mechanisms of formation and resolution of arteriovenous malformations.Cardiovasc Res. 2024 Dec 4;120(15):1967-1984. doi: 10.1093/cvr/cvae160. Cardiovasc Res. 2024. PMID: 39308243 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources